03.05.2017 18:00:00
|
bioMONTR Labs' Laboratory Director Receives Achievement Award
RESEARCH TRIANGLE PARK, N.C., May 3, 2017 /PRNewswire/ -- bioMONTR Labs is proud to announce that its Laboratory Director, Dr. Susan Fiscus, has been named as the 2017 recipient of the Ed Nowakowski Senior Memorial Clinical Virology Award presented by the Pan American Society for Clinical Virology. This accolade is awarded to individuals who have made a major impact on the epidemiology, treatment or understanding of the pathogenesis of viral diseases.
Prior to joining bioMONTR Labs, Dr. Fiscus served as the director of UNC's Retrovirology Core Laboratory. Preceding her 25-year career at UNC, Dr. Fiscus earned her bachelor's degree from Bates College, her master's degree in botany from Duke University and her doctoral degree in microbiology from Colorado State University. During her time at UNC, Fiscus worked on studies for the AIDS Clinical Trials Group (ACTG), the Pediatric ACTG, the HIV Prevention Trials Network, and the Centers for Disease Control (CDC) among other organizations.
Each year, PASCV's awards program provides an array of awards that recognize the contributions made by individuals to the field of clinical virology. These awards will be presented next week during the 2017 Clinical Virology Symposium in Savannah, Georgia.
About bioMONTR Labs:
bioMONTR Labs is a privately owned CLIA Certified lab located in Research Triangle Park, NC. The company offers a comprehensive menu of high-complexity molecular assays as well as other proprietary and esoteric molecular testing. Please visit http://www.biomontr.com for more information on the company, its management, test menu, and capabilities.
CONTACT DETAILS:
Anita M. McClernon
Vice President & Director of Laboratory Services
Email: amcclernon@biomontr.com
Phone: 1-866-609-3870 ext. 702
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomontr-labs-laboratory-director-receives-achievement-award-300450671.html
SOURCE bioMONTR Labs
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Red Robin Gourmet Burgers Inc.mehr Nachrichten
27.01.25 |
NASDAQ Composite Index-Papier Red Robin Gourmet Burgers-Aktie: So viel Verlust hätte ein Investment in Red Robin Gourmet Burgers von vor 5 Jahren eingebracht (finanzen.at) | |
24.01.25 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite schlussendlich im Minus (finanzen.at) | |
24.01.25 |
Handel in New York: NASDAQ Composite am Nachmittag in Rot (finanzen.at) | |
24.01.25 |
Handel in New York: NASDAQ Composite zum Start mit positivem Vorzeichen (finanzen.at) | |
20.01.25 |
NASDAQ Composite Index-Papier Red Robin Gourmet Burgers-Aktie: So viel Verlust wäre bei einem Investment in Red Robin Gourmet Burgers von vor 3 Jahren angefallen (finanzen.at) | |
15.01.25 |
Optimismus in New York: NASDAQ Composite zum Ende des Mittwochshandels mit positivem Vorzeichen (finanzen.at) | |
15.01.25 |
Pluszeichen in New York: NASDAQ Composite verbucht am Nachmittag Gewinne (finanzen.at) | |
15.01.25 |
Freundlicher Handel in New York: NASDAQ Composite zeigt sich zum Start fester (finanzen.at) |
Analysen zu Red Robin Gourmet Burgers Inc.mehr Analysen
Aktien in diesem Artikel
Red Robin Gourmet Burgers Inc. | 6,00 | 0,00% |